For heart disease, meds may work as well as invasive surgery, major trial shows

Philadelphia (CNN) According to a major trial, high-risk patients with stable heart disease can only fare on medications alone, versus aggressive cardiac operations such as stents and bypass surgeries. The results were presented at the annual conference of the American Heart Association on Saturday.

While invasive procedures were found to improve chest pain and quality of life in some patients, several important outcomes did not differ – namely, subsequent hospitalization for heart attack, unstable chest pain, or heart failure Recruiting after recruitment, cardiac arrest, and death. Due to cardiovascular reasons.

“Patients want to know, is this treatment going to keep me alive for a long time?” Said dr. Judith Hochman, Senior Associate Dean for Clinical Sciences at NYU Langone Health.

“Based on what we saw, we did not see evidence that would keep them alive for long.”
Stent and bypass surgery is commonly used for heart attack patients but is it to interfere with stable patients – who have blockages or chest pain during exercise but have a heart attack No – which has been hotly debated.

Patients with heart attacks were not included in the study, nor were other groups, including those with impaired cardiac muscle function or narrowing of the main coronary artery of the heart.

Cardiovascular Health – Heart
For heart disease, meds may work as well as invasive surgery, major trial shows

But when it came to patients with stable heart disease, “we selected patients with very unusual stress tests,” Hochman explained. “Was it thought that if someone was going to benefit from an aggressive strategy of stenting or bypass surgery, then they were the patients who would benefit.”

The researchers said the international trial, which began in 2012, involved more than 5,000 patients in 37 countries. Hochman said it produced two earlier studies that made similar conclusions but, in part because of how they were designed, failed to gain widespread acceptance among doctors.

If asymptomatic patients undergo invasive therapy, Hochman estimates the savings could be in the United States at hundreds of millions of dollars, based on earlier research.
“The implications are quite large globally and in the United States,” she said.

John Miller Willson
I am one of the project Head managers of the crew at blunt news. I have worked with various business magazines like Business Today, Business World, Outlook as a freelancer before joining the team. I am an addicted reader of self-help books, fictions, and journals.

Check out our latest